AngioChem Named as One of the “Fierce 15” Biotech Companies of 2012
9/19/2012 9:57:08 AM
MONTREAL--(BUSINESS WIRE)--Angiochem, a clinical stage biotechnology company, was named by FierceBiotech today as one of 2012’s Fierce 15, designating it as one of the most promising private biotechnology companies in the industry. This is FierceBiotech's tenth annual Fierce 15 selection.
comments powered by